Health-related Quality of Life in Patients with Waldenström Macroglobulinemia: Results from the ASPEN Trial.

Alessandra Tedeschi,Constantine S. Tam,Roger G. Owen,Christian Buske,Veronique Leblond,Meletios Dimopoulos,Ramon Garcia-Sanz,Jorge J. Castillo,Judith Trotman,Steven P. Treon,Keri Yang,Boxiong Tang,Heather Allewelt,Sheel Patel,Wai Y. Chan,Aileen Cohen, Shengnan Chen,Gisoo Barnes

Future Oncology（2024）

Cited 0|Views15

Key words

ASPEN trial,Bruton tyrosine kinase inhibitor,health-related quality of life,ibrutinib,patient-reported outcomes,Waldenstrom macroglobulinemia,zanubrutinib

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined